Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
292.8 USD | +1.17% | -2.92% | -9.51% |
Evolution of the average Target Price on Bio-Rad Laboratories, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Bio-Rad Laboratories, Inc.
Citigroup | |
RBC Capital Markets | |
UBS | |
Zacks Investment Research | |
Wells Fargo Securities | |
Credit Suisse | |
B. Riley |
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIO Stock
- Consensus Bio-Rad Laboratories, Inc.